RO7795068, RO7795068, RO7795068 Placebo, RO7795068, RO7795068, RO7795068, RO7795068
WC45726
Phase 3 small_molecule active
Quick answer
RO7795068, RO7795068, RO7795068 Placebo, RO7795068, RO7795068, RO7795068, RO7795068 for Obesity or Overweight and Type 2 Diabetes is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Obesity or Overweight and Type 2 Diabetes
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active